Questions Regarding the Value of CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann‐Vold et al
Zhou R, Wei X, Ma G, Zhu F, Chen F, Hu W. Questions Regarding the Value of CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann‐Vold et al. Arthritis & Rheumatology 2019, 71: 653-654. PMID: 30281217, DOI: 10.1002/art.40743.Peer-Reviewed Original Research